Sigma Genetics is developing its non-viral intracellular delivery platform (Magnetoporatorâ„¢ ) using magnetic fields to manufacture life-saving therapies and cellular products.
Total Funding: $11M
Total Funding: $17M
Total Funding: $1.7M